Three Novasep Custom Manufacturing Sites Renew FDA Approval in 2016


Novasep announces that three of its custom manufacturing sites individually passed the general inspection process of the US Food and Drug Administration (FDA) free of any 483 form.

All three FDA general inspections have taken place at Novasep’s manufacturing sites in France (Mourenx and Le Mans), and in Germany (Leverkusen) over the course of 2016.

Novasep’s manufacturing site in Le Mans, France, produces highly potent cytotoxic active pharmaceutical ingredients (HPAPI) and registered advanced intermediates for commercial or clinical development use. The site also provides customers with regulatory and containment evaluation support. It produces paclitaxel, for which Novasep holds a valid Drug Master File and a European CEP (Certificate of Suitability). The site is also renowned for Antibody Drug Conjugate (ADC) payload production services that will soon be extended to ADC conjugation.

The manufacturing site in Mourenx, France, produces APIs and advanced intermediates.

Novasep’s site in Leverkusen, Germany, amongst its set of technical expertise, can handle hazardous chemicals at industrial scale. This know-how is particularly suitable for designing shorter, cost-effective synthetic routes for producing APIs and advanced intermediates. The site also produces and sells pre-formulated nitroglycerin products for the pharmaceutical market.

In each case, the FDA inspection confirmed that commercial APIs produced at each site are suitable for drugs marketed in the US.

“This success has been made possible by the day-to-day good practices adopted by every colleague involved in operations. The robust system implemented by Novasep’s quality assurance team ensures these high standards,” said Jean-Claude Romain, VP quality at Novasep. “These three successful inspections reward this long-term teamwork and commitment.”

Global professional juries have recognized Novasep several times for the reliability and the robustness of its quality system.

More articles on this topic

ACHEMA 2022: The World Forum for the Process Industries on Site in Frankfurt Again

15.10.2021 -

After ACHEMA Pulse 2021 – the pioneering digital event for the process industry – ACHEMA 2022 is back in Frankfurt: from 4 to 8 April 2022, the Frankfurt Fairground will once again be the meeting place for the global process industries. In times of a pandemic, a comprehensive hygiene concept ensures that personal exchange and networking are once again possible in safety on site.

Read more

Positive Summary of ACHEMA Pulse

08.07.2021 -

After one month, ACHEMA Pulse came to an end on June 30, 2021. 960 exhibitors from 38 countries used the interactive platform to connect with a total of 15,000 attendees. A special highlight were the Live Days with almost 1,000 presentations. The organizers drew a positive conclusion of the event.

Read more
Directly to the product selection in